Summary:
Phase 3 Study. Approximately 2 or up to 4 years long. Visits are approximately every 3 months.
Qualified Participants Must:
• Have LVEF from Echo 35% or under documented in the past year
•
Be on heart failure medication
•
Be currently hospitalizated with primary reason of heart failure OR prior heart failure hospitalization, OR urgent heart failure admission to emergency department within 1 year prior to coming in for screening
Qualified Participants May Receive:
$60 per visit. This study will help find out if taking study drug can make people with heart failure feel better, have to go to the hospital less often, or live longer.